Research programme: G protein-coupled receptor modulators - Arena Pharmaceuticals/Eli LillyAlternative Names: GPCR modulators - Arena/Eli Lilly
Latest Information Update: 24 Jun 2003
At a glance
- Originator Arena Pharmaceuticals; Eli Lilly
- Mechanism of Action G protein-coupled receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cardiovascular disorders; CNS disorders
Most Recent Events
- 24 Jun 2002 Discontinued - Preclinical for CNS disorders in USA (unspecified route)
- 24 Jun 2002 Discontinued - Preclinical for Cardiovascular disorders in USA (unspecified route)
- 11 Jun 2001 Preclinical development for CNS disorders in USA (unspecified route)